Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Grossi and Matteo Bassetti.
Paolo Grossi
Connection Strength
0.443
Matteo Bassetti
  1. Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019 Apr; 53(4):408-415.
    View in: PubMed
    Score: 0.199
  2. The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
    View in: PubMed
    Score: 0.058
  3. Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort. Antimicrob Agents Chemother. 2018 04; 62(4).
    View in: PubMed
    Score: 0.048
  4. Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther. 2018 04; 16(4):307-320.
    View in: PubMed
    Score: 0.047
  5. The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts. J Chemother. 2018 May; 30(3):157-171.
    View in: PubMed
    Score: 0.047
  6. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017 Aug; 29(4):197-214.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.